Avinger Inc. is counting on the growing evidence base supporting its flagship Pantheris directional atherectomy system, along with forthcoming upgrades to the device, to revive the company's revenues and sagging stock price.
Pantheris is built on Avinger's unique Lumivascular technology, which allows a laser-imaging system to be mounted on a catheter tool that removes material blocking an artery. "The technology is centered...